Bryan Humbarger Appointed Chief Commercial Officer at HeartBeam

HeartBeam has appointed Bryan Humbarger as Chief Commercial Officer, effective January 22, 2026. Humbarger will lead commercial strategy and execution for the company's key growth initiatives, including the limited launch of the HeartBeam System for arrhythmia assessment and heart attack detection. With over 25 years of commercial leadership experience, Humbarger will focus on outreach to the cardiology community, developing partnerships with channel partners and prominent cardiology practices. He will establish reference sites and drive growth in the years ahead.